Previous close | 66.15 |
Open | 65.74 |
Bid | 65.38 x 350000 |
Ask | 65.61 x 350000 |
Day's range | 65.74 - 65.74 |
52-week range | 51.19 - 68.14 |
Volume | |
Avg. volume | 1 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, June 26, 2024--MetLife, Inc. (NYSE: MET) has published its 2023 Sustainability Report on how the company is living its purpose – Always with you, building a more confident future – through the strength of its people, products, services, and investments.
NEW YORK, June 25, 2024--MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberm
OLDWICK, N.J., June 20, 2024--AM Best has assigned a Long-Term Issue Credit Rating of "a-" (Excellent) to the newly issued $500 million, 5.300% senior unsecured notes due Dec. 15, 2034, issued by MetLife, Inc. (MetLife) (headquartered in New York, NY) [NYSE: MET]. The outlook assigned to this Credit Rating (rating) is stable. All other ratings of MetLife and its subsidiaries remain unchanged.